Table 2.
Patients with primary ICC treated by SMWA.
| Patient | Age at SMWA | Gender | Child Score | Underlying Liver Disease | Segment | Tumor Size (mm) | Previous Treatment | Complications > Dindo IIIa | Local Recurrence | Time to Recurrence (Months) | Treatment of Recurrence | Death | OS (Months) | Time to Transplant (Months) | Overall Disease Progression |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 31 | M | B7 | PSC | V | 20 | no | no | no | no | 31.5 | 10 | no | ||
| 2 | 58 | M | A6 | HCV | VIII | 23 | no | no | yes | 18 | TAE + MWA planned | no | 19 | N/A | no |
| 3 | 64 | M | A6 | ASH/NASH | VIII | 15 | TAE | no | no | no | 12 | N/A | no | ||
| 4 | 58 | M | A5 | NASH | VI | 24 | no | no | no | no | 10 | on waiting list | yes (HCC) | ||
| 5 | 81 | M | A5 | Unknown | V/VIII | 27 | No | no | no | no | 6 | no |
Gender: M = male, F = female; OS = overall survival; HCV = hepatitis C; PSC = primary sclerosing cholangitis; TAE = transarterial embolization; ASH = alcoholic steatohepatitis; NASH = non-alcoholic steatohepatitis.